A South Jersey life sciences company developing a blood test for the early detection of Alzheimer's and Parkinson's disease, when treatments are likely to be more effective, has raised $3.5 million in equity financing. The private stock sale was disclosed by Durin Technologies Inc. of Mullica Hill in documents filed with the Securities and Exchange Commission. Please read more here.